...
首页> 外文期刊>The journal of asthma >Increasing use of non-invasive ventilation in asthma: a long-term analysis of the Portuguese national hospitalization database
【24h】

Increasing use of non-invasive ventilation in asthma: a long-term analysis of the Portuguese national hospitalization database

机译:在哮喘中越来越多地使用无创通气:葡萄牙国家住院数据库的长期分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To describe the use and outcomes of non-invasive positive pressure ventilation (NPPV) and invasive ventilation (IV) in adults hospitalized for acute asthma exacerbations in Portugal. Methods: We analyzed the hospitalizations of adults with a principal diagnosis of asthma in mainland Portugal between 2000 and 2010. The data source was the national hospitalizations database, which includes administrative and clinical data produced by physicians trained in coding. Results: Ventilation support was used in 5.1% (n = 747) of the 14 515 hospitalizations with a principal diagnosis of asthma: NPPV in 1.7% (n = 241) and IV in 3.5% (n = 506); NPPV use increased from 1% in 2000 to 3.3% in 2010. In patients with asthma, the ratio of NPPV use to IV use increased from 0.27 to 1.06. This increase was observed even after exclusion of secondary diagnoses in which NPPV is frequently used. The mortality rate was 1.5% for all asthma hospitalizations: 2.5% when NPPV was used and 15.8% for those requiring IV. Conclusions: The use of ventilation support in asthma remained stable over time; however, the use of non-invasive ventilation has increased. Still, we do not have good data regarding the effectiveness of non-invasive ventilation when treating asthma exacerbations. Therefore, additional studies are much needed and should assess physiologic and clinical variables that might affect the effectiveness of non-invasive ventilation in patients with asthma exacerbations.
机译:描述在葡萄牙因急性哮喘急性发作住院的成年人中无创正压通气(NPPV)和有创通气(IV)的使用和结果。方法:我们分析了2000年至2010年间在葡萄牙大陆上主要诊断为哮喘的成人住院情况。数据来源为国家住院数据库,其中包括接受过编码培训的医师提供的行政和临床数据。结果:14 515例主要诊断为哮喘的住院患者中,有5.1%(n = 747)接受了通气支持:NPPV占1.7%(n = 241),IV占3.5%(n = 506); NPPV使用率从2000年的1%增加到2010年的3.3%。在哮喘患者中,NPPV使用率与IV使用率之比从0.27增加到1.06。即使排除了经常使用NPPV的继发诊断后,也观察到了这种增加。所有哮喘住院患者的死亡率均为1.5%:使用NPPV时死亡率为2.5%,需要静脉注射者为15.8%。结论:通气支持在哮喘中的使用随着时间的推移保持稳定。然而,无创通气的使用增加了。但是,对于治疗哮喘加重时无创通气的有效性,我们还没有很好的数据。因此,急需进行更多的研究,并应评估可能影响哮喘急性发作患者无创通气有效性的生理和临床变量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号